Stay informed with the latest updates for the inheritable blood disorders community. Industry FDA Grants Breakthrough Status to BIVV001 Jun 1, 2022 Industry FDA Accepts Priority Review BLA for Hemophilia B Gene TherapyMay 24, 2022 Medical Bone Health in VWD and Hemophilia Carriers the Focus of Retrospective…May 9, 2022 Medical New Data Shows Eptacog Beta Safe and Effective in Pediatric PatientsApr 29, 2022 Medical Six New MASAC Documents IssuedApr 28, 2022 Medical NHLBI Grant Supports Scientific Research to Enhance Hemophilia A Gene…Apr 4, 2022 Industry First Patient Dosed in Freeline’s Dose-Confirmation Trial for…Mar 25, 2022 NBDF & Community Starting the Conversation with Dr. Johnny MahlanguFeb 25, 2022 Medical New Medscape Activity Seeks to Prepare Clinicians for Gene TherapyJan 28, 2022 Industry BioMarin Provides Update Including Next Steps for Investigational Gene…Jan 11, 2022 Medical New Study Looks at Physical Activity Risk in Patients with Hemophilia ADec 28, 2021 Industry Sigilon Announces a Priority Shift in Light of Clinical Trial SetbacksDec 17, 2021 Medical Clinical Study and New Website to Focus on von Willebrand Disease and…Dec 14, 2021 Industry uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene…Dec 9, 2021 Industry Sigilon Reports Trial Updates for Investigational Hemophilia A Therapy Nov 29, 2021 Pagination First page Previous page … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Last page